[ad_1]
The government should encourage pharmaceutical companies to develop "urgent" medicines to fight AMR (Antimicrobial Resistant Superbugs). The Secretary of State for Health warned, "We are at the dawn of a world where a simple pasture could be deadly".
According to the plans, the inappropriate use of antibiotics would also be reduced by 15%, which would reduce resistant infections and would save thousands of lives in the UK.
The pharmaceutical industry is attacking criticism that it is reluctant to conduct research in the region because it is potentially less profitable than revolutionary drugs.
US Secretary of Health Matt Hanbad is scheduled to announce his proposals Thursday at the World Economic Forum in Davos, in which he will advocate that antimicrobial treatment be treated as a "global health emergency" that poses such a serious threat to the world. humanity as climate change.
"Imagine a world without antibiotics. Where treatable infections become impossible to treat, where routine surgery such as a hip operation becomes too risky, and where every injury is potentially life-threatening, "should we expect Hanbad.
"What would you pbad through the head if your child cut his finger and you knew that there was no longer any antibiotic capable of treating an infection? It was the human condition until almost a century ago. I do not want it to be the future of my children, but maybe it is less that we act.
"All of us benefit from antibiotics, but we take them too easily for granted, and I shudder at the thought of a world in which their power is diminished. Antimicrobial resistance is as dangerous to humanity as climate change or war. That's why we need an urgent global response. "
Work to introduce the new payment model will be underway in six months, the government aiming to reduce by 5,000 or 10% the number of drug-resistant infections by 2025 – and to prevent at least 15,000 patients a year to contract infections as a result of their health care by 2024.
The O'Neill report, a 2016 study commissioned by the government, will badess the potential impact of antimicrobial resistance. It is a major threat to modern medicine and is expected to kill 10 million people each year by 2050.
According to official figures, in the UK, about 2,000 people die each year from resistant infections. At least 20% of antibiotics used in primary care have been prescribed inappropriately, according to official figures.
A lack of effective antibiotics could make simple operations, such as caesareans or hip replacements, too dangerous. The number of drug-resistant blood infections, such as super-gonorrhea, increased by 35% between 2013 and 2017.
Theresa May, Prime Minister, said: "The increase in antibiotic resistance is a threat that we can not afford to ignore. It is essential to fight the spread of drug-resistant infections before routine operations and minor illnesses are life-threatening.
"I am very proud of the UK's global leadership on this important agenda. We will continue to work with our partners to lead an international action that will protect the health of future generations. "
In a statement, the health department said, "The way drug companies are paid depends on the volumes sold, which makes them sell as much antibiotics as possible, along with the government's willingness to reduce the use of antibiotics.
"Low returns on investment in development mean that the industry is not innovating enough, and as a result, very few of the new drugs currently under development are targeted at priority infections."
The National Institute for Health and Care Excellence and the NHS England will examine how a new payment model could remunerate pharmaceutical companies for their drugs based on their value to the health service, rather than simply on the amount of money they pay for it. antibiotics sold.
It is hoped that this would encourage companies to invest in the development of drugs to treat highly resistant infections. The UK has reduced its amount of antibiotics by more than 7% since 2014.
Source link
